The Technical AnalystExchange: ASX Industry: Materials
Clover Corporation Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.92% $0.510
America/New_York / 2 mai 2024 @ 23:58
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 85.17 mill |
| EPS: | 0.0100 |
| P/E: | 51.00 |
| Earnings Date: | Mar 19, 2024 |
| SharesOutstanding: | 167.00 mill |
| Avg Daily Volume: | 0.103 mill |
| RATING 2024-05-02 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/21 | 1/22 | 3/22 | 1/23 | 3/23 | 1/24 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 40.55x |
| Company: PE 51.00 | sector: PE 1.258 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 6.88x |
| Company: PE 51.00 | industry: PE 7.41 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$1.229 (140.93%) $0.719 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.492 - 0.548 ( +/- 5.38%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.510 (-1.92% ) |
| Volume | 0.0449 mill |
| Avg. Vol. | 0.103 mill |
| % of Avg. Vol | 43.61 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CLV.AX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CLV.AX
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy livingbrain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.